Innovations for Emphysema

Emphysema causes progressive breathlessness, and these patients are suffering quite dramatically. Dr. med. Dirk-Jan Slebos, PhD – UMC Groningen – The Netherlands
All the medical and non-pharmacological options we have do not work anymore, so we need more and better treatments for our patients with COPD. Dr. Pallav Shah, MD – Royal Brompton & Harefield London – United Kingdom

Emphysema is an advanced form of chronic obstructive pulmonary disease – also known as COPD – which is progressive and, over time, leads to ongoing breathlessness.

It can make everyday activities, such as eating, walking, housework, even brushing teeth, challenging and can cause extreme fatigue. Some studies suggest that the quality of life for emphysema patients is even worse than end-stage lung cancer.

Pulmonx strives to improve the lives of patients suffering from emphysema, an advanced form of Chronic Obstructive Pulmonary Disease (COPD).

The company’s minimally invasive, precision technologies for interventional pulmonology are designed to improve pulmonary function, exercise capacity and quality of life in emphysema patients.

Hear leading physicians discuss emphysema and the promise of Pulmonx products

CAUTION: The Zephyr Endobronchial Valve is an investigational device in the US, limited by US law to investigational use.